# Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency

> **NCT00554814** · NA · SUSPENDED · sponsor: **Bledina** · enrollment: 249 (estimated)

## Conditions studied

- Latent Iron Deficiency

## Interventions

- **DRUG:** Bledilait Biofer®
- **DRUG:** Milk supplemented with ferrous sulphate
- **DRUG:** Blédilait Biofer®

## Key facts

- **NCT ID:** NCT00554814
- **Lead sponsor:** Bledina
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2007-11
- **Primary completion:** 2008-11
- **Final completion:** 2008-12
- **Target enrollment:** 249 (ESTIMATED)
- **Why stopped:** insufficient recruitment
- **Last updated:** 2008-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00554814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00554814, "Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00554814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*